AAPL   317.94 (+0.43%)
FB   222.30 (+0.38%)
MSFT   167.28 (+0.47%)
GOOGL   1,495.13 (+0.87%)
AMZN   1,901.83 (+0.52%)
CGC   23.93 (-0.91%)
NVDA   251.42 (+1.40%)
BABA   223.95 (+0.76%)
MU   59.29 (+0.53%)
TSLA   573.40 (+4.79%)
AMD   51.56 (+1.00%)
T   38.86 (+0.88%)
ACB   1.95 (-2.99%)
F   9.22 (+0.00%)
NFLX   328.77 (-2.76%)
PRI   127.45 (+0.82%)
BAC   34.30 (+0.12%)
DIS   144.25 (+0.48%)
GILD   63.00 (+0.59%)
AAPL   317.94 (+0.43%)
FB   222.30 (+0.38%)
MSFT   167.28 (+0.47%)
GOOGL   1,495.13 (+0.87%)
AMZN   1,901.83 (+0.52%)
CGC   23.93 (-0.91%)
NVDA   251.42 (+1.40%)
BABA   223.95 (+0.76%)
MU   59.29 (+0.53%)
TSLA   573.40 (+4.79%)
AMD   51.56 (+1.00%)
T   38.86 (+0.88%)
ACB   1.95 (-2.99%)
F   9.22 (+0.00%)
NFLX   328.77 (-2.76%)
PRI   127.45 (+0.82%)
BAC   34.30 (+0.12%)
DIS   144.25 (+0.48%)
GILD   63.00 (+0.59%)
AAPL   317.94 (+0.43%)
FB   222.30 (+0.38%)
MSFT   167.28 (+0.47%)
GOOGL   1,495.13 (+0.87%)
AMZN   1,901.83 (+0.52%)
CGC   23.93 (-0.91%)
NVDA   251.42 (+1.40%)
BABA   223.95 (+0.76%)
MU   59.29 (+0.53%)
TSLA   573.40 (+4.79%)
AMD   51.56 (+1.00%)
T   38.86 (+0.88%)
ACB   1.95 (-2.99%)
F   9.22 (+0.00%)
NFLX   328.77 (-2.76%)
PRI   127.45 (+0.82%)
BAC   34.30 (+0.12%)
DIS   144.25 (+0.48%)
GILD   63.00 (+0.59%)
AAPL   317.94 (+0.43%)
FB   222.30 (+0.38%)
MSFT   167.28 (+0.47%)
GOOGL   1,495.13 (+0.87%)
AMZN   1,901.83 (+0.52%)
CGC   23.93 (-0.91%)
NVDA   251.42 (+1.40%)
BABA   223.95 (+0.76%)
MU   59.29 (+0.53%)
TSLA   573.40 (+4.79%)
AMD   51.56 (+1.00%)
T   38.86 (+0.88%)
ACB   1.95 (-2.99%)
F   9.22 (+0.00%)
NFLX   328.77 (-2.76%)
PRI   127.45 (+0.82%)
BAC   34.30 (+0.12%)
DIS   144.25 (+0.48%)
GILD   63.00 (+0.59%)
Log in
(Ad)
CNN calls 5G "the lifeblood of the new economy." If you don't invest now, you'll regret it later.

NYSEAMERICAN:TRXC - TransEnterix Stock Price, Forecast & News

$1.43
+0.04 (+2.88 %)
(As of 01/22/2020 09:57 AM ET)
Today's Range
$1.43
Now: $1.43
$1.43
50-Day Range N/A
52-Week Range
$1.35
Now: $1.43
$43.29
Volume2 shs
Average Volume3.47 million shs
Market Capitalization$28.11 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
TransEnterix, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. Read More…

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:TRXC
CUSIPN/A
Phone+1-919-7658400

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$28.11 million
Next Earnings Date2/25/2020 (Estimated)
OptionableOptionable

Receive TRXC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRXC and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

One undiscovered bank expects to pay out $332 million in 2019! And now's your chance to claim a 10.6% dividend - with MONTHLY PAYMENTS.

This FREE special report reveals important details - including NAME, TICKER SYMBOL, and urgent payment information.

TransEnterix (NYSEAMERICAN:TRXC) Frequently Asked Questions

What is TransEnterix's stock symbol?

TransEnterix trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "TRXC."

How were TransEnterix's earnings last quarter?

TransEnterix, Inc. (NYSEAMERICAN:TRXC) announced its quarterly earnings data on Tuesday, November, 12th. The medical instruments supplier reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.07) by $0.02. The medical instruments supplier earned $2.02 million during the quarter, compared to analysts' expectations of $4.68 million. View TransEnterix's Earnings History.

When is TransEnterix's next earnings date?

TransEnterix is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for TransEnterix.

What price target have analysts set for TRXC?

3 equities research analysts have issued 12-month target prices for TransEnterix's shares. Their forecasts range from $1.00 to $3.00. On average, they anticipate TransEnterix's share price to reach $1.87 in the next year. This suggests a possible upside of 30.5% from the stock's current price. View Analyst Price Targets for TransEnterix.

What is the consensus analysts' recommendation for TransEnterix?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TransEnterix in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for TransEnterix.

Has TransEnterix been receiving favorable news coverage?

Media headlines about TRXC stock have trended negative on Wednesday, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. TransEnterix earned a news sentiment score of -2.0 on InfoTrie's scale. They also assigned news stories about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for TransEnterix.

Are investors shorting TransEnterix?

TransEnterix saw a increase in short interest in December. As of December 31st, there was short interest totalling 2,380,000 shares, an increase of 14.4% from the December 15th total of 2,080,000 shares. Based on an average daily trading volume, of 424,700 shares, the short-interest ratio is presently 5.6 days. Approximately 15.4% of the shares of the stock are short sold. View TransEnterix's Current Options Chain.

Who are some of TransEnterix's key competitors?

What other stocks do shareholders of TransEnterix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TransEnterix investors own include Oramed Pharmaceuticals (ORMP), Compugen (CGEN), Editas Medicine (EDIT), Ekso Bionics (EKSO), XOMA (XOMA), Actinium Pharmaceuticals (ATNM), Geron (GERN), NVIDIA (NVDA), Opko Health (OPK) and Advanced Micro Devices (AMD).

Who are TransEnterix's key executives?

TransEnterix's management team includes the folowing people:
  • Mr. Todd M. Pope, CEO, Pres & Director (Age 53)
  • Mr. Joseph P. Slattery, Exec. VP, CFO & Principal Accounting Officer (Age 53)
  • Mr. Anthony Fernando, COO, CTO & Exec. VP (Age 46)
  • Mr. Joshua B. Weingard, Chief Legal Officer & Sec. (Age 45)
  • Dr. Stephanie M. Fitts Ph.D., VP of RA/QA, Clinical and Compliance (Age 52)

How do I buy shares of TransEnterix?

Shares of TRXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is TransEnterix's stock price today?

One share of TRXC stock can currently be purchased for approximately $1.43.

How big of a company is TransEnterix?

TransEnterix has a market capitalization of $28.11 million. View Additional Information About TransEnterix.

What is TransEnterix's official website?

The official website for TransEnterix is http://www.transenterix.com/.

How can I contact TransEnterix?

TransEnterix's mailing address is 635 Davis Dr Ste 300, MORRISVILLE, NC 27560-7199, United States. The medical instruments supplier can be reached via phone at +1-919-7658400.


MarketBeat Community Rating for TransEnterix (NYSEAMERICAN TRXC)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  399 (Vote Outperform)
Underperform Votes:  453 (Vote Underperform)
Total Votes:  852
MarketBeat's community ratings are surveys of what our community members think about TransEnterix and other stocks. Vote "Outperform" if you believe TRXC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRXC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2020 by MarketBeat.com Staff

Featured Article: What is a Call Option?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel